(Given the potential long-term consequences of NMOSD relapses, the company could not ethically include a direct placebo arm in its Phase III trial.) Ultomiris was well-tolerated overall, and most treatment-emergent events were mild or moderate in severity, according to AstraZeneca
The safety and effectiveness of FARXIGA have not been established in pediatric patients to reduce the risk of [see Indications and Usage (1)]: sustained eGFR decline, end-stage kidney disease, CV death, and hospitalization for heart failure in patients with chronic kidney disease at risk of progression
Instead of having to be broken down like food, the liposome can fuse directly with the cells lining your gut
You avoid coverage gaps entirely while still getting effective treatment under medical supervision
B-12 deficiency slows the production of red blood cells, causing a condition called anemia